CoreValve becomes first transcatheter heart valve approved for valve-in-valve procedures. Chris Newmarker Rendering of the CoreValve right after its transcatheter deployment. (Image courtesy of Medtronic) FDA has cleared the way for ...
Tags: FDA, Medicine, Medical Device
Medtronic has seen its fair share of bad patent news of late. Last year, the company agreed to pony up more than $1 billion to settle patent litigation with Edwards Lifesciences. Now, the company stands to lose out on a significant cash ...
Tags: Medtronic, Medical Device
Posted in Medical Device Business by Chris Newmarker on December 11, 2014 2014 has turned out to be a pretty decent year for the world’s 40 largest medical device companies: Only six of them have seen their stock prices decline, and ...
Tags: Medical Device, Health
This year is proving to be a pretty good year for many medtech companies. The majority of the largest 40 have seen their stock prices rise by double-digit percentages in 2014, according to a Qmed analysis. Meanwhile, only eight have seen ...
Tags: Medtech Companies, Medical device
Edwards' Sapien XT transcatheter aortic heart valve (Courtesy Edwards Lifesciences) Edwards Lifesciences Corp. (Irvine, CA) has announced both the FDA approval and the U.S. launch of its next-generation Sapien XT transcatheter aortic ...
Tags: Health, Medicine, heart valve
Two new reports from iData Research cover the US market for vascular access devices and the European markets for cardiac surgery and heart valve devices. The European interventional cardiology report covers markets for tissue heart ...
Tags: Medtech Markets, US market
Medtronic's CoreValve transcatheter aortic valve replacement device. (Courtesy Medtronic) Almost before the judge's signature was dry on Friday's federal district court preliminary injunction in favor of Edwards Lifesciences Corp. ...
Edwards Lifesciences has received regulatory approval to sell its third-generation Sapien 3 transcatheter aortic heart valve in Europe. Edwards Lifescience's Sapien 3 could be used in a broader range of patients than earlier TAVR ...
Tags: Sapien, Medtronic', CoreValve
Medtronic willfully infringed on an Edwards Lifesciences’ patent with its CoreValve transcatheter heart valve, and owes Edwards nearly $394 million in damages and patent royalties, a federal jury in Delaware found Wednesday. Edwards ...
Tags: Medtronic, CoreValve, transcatheter heart valve, Edwards
Direct Flow Medical (Santa Rosa, CA) has obtained the CE Mark for its 29-mm transcatheter aortic valve replacement device, which it hails as the first fully repositionable percutaneous heart valve. The ability to reposition the Direct Flow ...
For the medtech industry, 2014 is unlikely to be a year full of surprises as companies grapple with a health care market wary of big-ticket procedures and items. The largest gains will likely involve digital health and other technologies ...
The largest medical device companies have had a good run on the stock markets this year, with many clocking in double-digit percentage growth in stock prices over the past 12 months. There are always exceptions to the rule, however. Here ...
Tags: Medical Device, Medical Device Firms, Worst Performing Firms
Posted in Cardiovascular by Qmed Staff on November 19, 2013 The Sapien 3 could be used in a broader range of patients than earlier TAVR products introduced internationally. Edwards Lifesciences (Irvine, CA) is in the news after The ...
In August, Medtronic was forced to remove its CoreValve percutaneuous heart valves from the market in Germany in light of a ruling that found that the device infringed on patents held by Edwards Lifesciences. A German appeals court, ...
Edwards Lifesciences announced that the injunction imposed by the District Court of Mannheim, Germany against the sales of Medtronic's transcatheter heart valves has become effective. In July 2013, the court ruled that Medtronic's ...
Tags: Heart Valves, Medicine